Form 8-K · Current report
GE HealthCare 8-K, filed Jul 23, 2026
- Filed
- CIK
- 0001932393
- Accession no.
- 0001932393-26-000039
Summary
GE HealthCare said Chief Financial Officer Jay Saccaro will step down effective August 14, 2026 to take a role outside the medical technology industry, and named Controller and Chief Accounting Officer George Newcomb as interim CFO while it searches for a permanent successor. The company also reported preliminary second quarter 2026 revenue growth of 5.7% year over year (3.5% organic), said adjusted EPS was ahead of its prior expectation, and reaffirmed its full-year 2026 guidance.
Key points
- GE HealthCare expects preliminary second quarter 2026 revenue of $5,295 million, up 5.7% year over year, with organic revenue growth of 3.5%.
- Adjusted EPS for the quarter is expected to come in above the company's prior expectation, and full-year 2026 guidance issued April 29, 2026 is reaffirmed.
- Jay Saccaro's last day as CFO is August 14, 2026; he said he is leaving for a role outside the medical technology industry.
- George Newcomb, 59, currently Controller and Chief Accounting Officer, becomes interim CFO on August 14, 2026, with no change to his compensation arrangements; a search for a permanent successor has begun.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operation and Financial Condition On July 23, 2026, GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing preliminary unaudited revenue and earnings per share (“EPS”) results for second quarter 2026. A copy of this press release is furnished as Exhibit 99 to this Current Report on Form 8-K. The information furnished pursuant to Item 2.02, including Exhibit 99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of GE HealthCare under the…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.